CN108586532B - 一种富马酸替诺福韦二吡呋酯的制备方法 - Google Patents
一种富马酸替诺福韦二吡呋酯的制备方法 Download PDFInfo
- Publication number
- CN108586532B CN108586532B CN201810296698.4A CN201810296698A CN108586532B CN 108586532 B CN108586532 B CN 108586532B CN 201810296698 A CN201810296698 A CN 201810296698A CN 108586532 B CN108586532 B CN 108586532B
- Authority
- CN
- China
- Prior art keywords
- stirring
- tenofovir disoproxil
- tenofovir
- solution
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 title claims abstract description 193
- 229960004693 tenofovir disoproxil fumarate Drugs 0.000 title claims abstract description 86
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 222
- 238000007670 refining Methods 0.000 claims abstract description 37
- 238000006266 etherification reaction Methods 0.000 claims abstract description 17
- 230000007062 hydrolysis Effects 0.000 claims abstract description 17
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 17
- 238000009833 condensation Methods 0.000 claims abstract description 16
- 230000005494 condensation Effects 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims description 268
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 228
- 239000000243 solution Substances 0.000 claims description 178
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 114
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 112
- 238000001816 cooling Methods 0.000 claims description 105
- 229960004556 tenofovir Drugs 0.000 claims description 89
- 239000012043 crude product Substances 0.000 claims description 87
- 239000000047 product Substances 0.000 claims description 86
- 229960001355 tenofovir disoproxil Drugs 0.000 claims description 84
- JFVZFKDSXNQEJW-CQSZACIVSA-N tenofovir disoproxil Chemical compound N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N JFVZFKDSXNQEJW-CQSZACIVSA-N 0.000 claims description 84
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 80
- 238000010438 heat treatment Methods 0.000 claims description 76
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 72
- 238000005406 washing Methods 0.000 claims description 69
- 239000010410 layer Substances 0.000 claims description 66
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 63
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 57
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 54
- 239000007787 solid Substances 0.000 claims description 50
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 49
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 49
- 238000001035 drying Methods 0.000 claims description 48
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 47
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 44
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 44
- 239000000706 filtrate Substances 0.000 claims description 41
- MJZYTEBKXLVLMY-RXMQYKEDSA-N (2r)-1-(6-aminopurin-9-yl)propan-2-ol Chemical compound N1=CN=C2N(C[C@H](O)C)C=NC2=C1N MJZYTEBKXLVLMY-RXMQYKEDSA-N 0.000 claims description 40
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 38
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 37
- 239000001530 fumaric acid Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 33
- 150000002148 esters Chemical class 0.000 claims description 31
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 30
- 238000004537 pulping Methods 0.000 claims description 30
- 239000012065 filter cake Substances 0.000 claims description 28
- 238000001914 filtration Methods 0.000 claims description 26
- 239000000741 silica gel Substances 0.000 claims description 25
- 229910002027 silica gel Inorganic materials 0.000 claims description 25
- 239000012153 distilled water Substances 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- JHYNXXBAHWPABC-UHFFFAOYSA-N chloromethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OCCl JHYNXXBAHWPABC-UHFFFAOYSA-N 0.000 claims description 22
- KTVKQTNGWVJHFL-UHFFFAOYSA-N 2-ethylchromen-4-one Chemical compound C1=CC=C2OC(CC)=CC(=O)C2=C1 KTVKQTNGWVJHFL-UHFFFAOYSA-N 0.000 claims description 21
- UOEFFQWLRUBDME-UHFFFAOYSA-N diethoxyphosphorylmethyl 4-methylbenzenesulfonate Chemical compound CCOP(=O)(OCC)COS(=O)(=O)C1=CC=C(C)C=C1 UOEFFQWLRUBDME-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims description 19
- 239000008213 purified water Substances 0.000 claims description 19
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 18
- IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 claims description 16
- 238000005352 clarification Methods 0.000 claims description 16
- 238000001291 vacuum drying Methods 0.000 claims description 16
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- 238000007664 blowing Methods 0.000 claims description 15
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 15
- 239000005457 ice water Substances 0.000 claims description 15
- 238000010907 mechanical stirring Methods 0.000 claims description 15
- 239000012044 organic layer Substances 0.000 claims description 15
- 238000010791 quenching Methods 0.000 claims description 15
- 230000000171 quenching effect Effects 0.000 claims description 15
- 239000011780 sodium chloride Substances 0.000 claims description 15
- 238000006276 transfer reaction Methods 0.000 claims description 15
- 238000007789 sealing Methods 0.000 claims description 10
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims description 9
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 9
- 239000007789 gas Substances 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000012265 solid product Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- ONRREFWJTRBDRA-UHFFFAOYSA-N 2-chloroethanamine;hydron;chloride Chemical compound [Cl-].[NH3+]CCCl ONRREFWJTRBDRA-UHFFFAOYSA-N 0.000 claims description 8
- 229930024421 Adenine Natural products 0.000 claims description 8
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 8
- 229960000643 adenine Drugs 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 238000000967 suction filtration Methods 0.000 claims description 8
- XTVNGRMJOGNDOG-UHFFFAOYSA-N 1-trimethoxysilylpropan-2-yl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CC(C)OC(=O)C(C)=C XTVNGRMJOGNDOG-UHFFFAOYSA-N 0.000 claims description 7
- CHJQIQKMTVZYFQ-UHFFFAOYSA-N diethoxyphosphoryloxymethyl 4-methylbenzenesulfonate Chemical compound CCOP(=O)(OCC)OCOS(=O)(=O)C1=CC=C(C)C=C1 CHJQIQKMTVZYFQ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 54
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 34
- 229960000583 acetic acid Drugs 0.000 description 34
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 27
- -1 diethyl p-toluenesulfonate phosphate Chemical compound 0.000 description 18
- 239000012535 impurity Substances 0.000 description 18
- 229960004424 carbon dioxide Drugs 0.000 description 17
- 235000011089 carbon dioxide Nutrition 0.000 description 17
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 238000002425 crystallisation Methods 0.000 description 13
- 230000008025 crystallization Effects 0.000 description 13
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 11
- SGOIRFVFHAKUTI-ZCFIWIBFSA-N tenofovir (anhydrous) Chemical compound N1=CN=C2N(C[C@@H](C)OCP(O)(O)=O)C=NC2=C1N SGOIRFVFHAKUTI-ZCFIWIBFSA-N 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- 239000012085 test solution Substances 0.000 description 9
- 238000005303 weighing Methods 0.000 description 8
- 238000007865 diluting Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 description 2
- RUOJZAUFBMNUDX-GSVOUGTGSA-N (4r)-4-methyl-1,3-dioxolan-2-one Chemical compound C[C@@H]1COC(=O)O1 RUOJZAUFBMNUDX-GSVOUGTGSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000013557 residual solvent Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
- CTKINSOISVBQLD-VKHMYHEASA-N (S)-Glycidol Chemical compound OC[C@H]1CO1 CTKINSOISVBQLD-VKHMYHEASA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- LERQUXNTWJVTCU-SNVBAGLBSA-N 9-[(2R)-2-[bis(ethylperoxy)phosphorylmethoxy]propyl]purin-6-amine Chemical compound C(C)OOP(=O)(OOCC)CO[C@@H](CN1C2=NC=NC(=C2N=C1)N)C LERQUXNTWJVTCU-SNVBAGLBSA-N 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-GSVOUGTGSA-N R-propylene oxide Chemical compound C[C@@H]1CO1 GOOHAUXETOMSMM-GSVOUGTGSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZAAQMNVHSKISRP-UHFFFAOYSA-N di(propan-2-yloxy)phosphorylmethyl 4-methylbenzenesulfonate Chemical compound CC(C)OP(=O)(OC(C)C)COS(=O)(=O)C1=CC=C(C)C=C1 ZAAQMNVHSKISRP-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- UJKWLAZYSLJTKA-UHFFFAOYSA-N edma Chemical compound O1CCOC2=CC(CC(C)NC)=CC=C21 UJKWLAZYSLJTKA-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical group [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- LPEKGGXMPWTOCB-GSVOUGTGSA-N methyl (R)-lactate Chemical compound COC(=O)[C@@H](C)O LPEKGGXMPWTOCB-GSVOUGTGSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- PUUZLWLFYQFYCF-UHFFFAOYSA-N n-ethylethanamine;hexane;propan-2-ol Chemical compound CC(C)O.CCNCC.CCCCCC PUUZLWLFYQFYCF-UHFFFAOYSA-N 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 description 1
- XRBCRPZXSCBRTK-UHFFFAOYSA-N phosphonous acid Chemical compound OPO XRBCRPZXSCBRTK-UHFFFAOYSA-N 0.000 description 1
- 238000000711 polarimetry Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- IXXMVXXFAJGOQO-RXMQYKEDSA-N tert-butyl (2r)-2-hydroxypropanoate Chemical compound C[C@@H](O)C(=O)OC(C)(C)C IXXMVXXFAJGOQO-RXMQYKEDSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810296698.4A CN108586532B (zh) | 2018-04-03 | 2018-04-03 | 一种富马酸替诺福韦二吡呋酯的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810296698.4A CN108586532B (zh) | 2018-04-03 | 2018-04-03 | 一种富马酸替诺福韦二吡呋酯的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108586532A CN108586532A (zh) | 2018-09-28 |
CN108586532B true CN108586532B (zh) | 2020-05-08 |
Family
ID=63625440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810296698.4A Active CN108586532B (zh) | 2018-04-03 | 2018-04-03 | 一种富马酸替诺福韦二吡呋酯的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108586532B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110041369A (zh) * | 2019-02-28 | 2019-07-23 | 湖北益泰药业股份有限公司 | 一种高纯度的富马酸替诺福韦二吡呋酯的制备方法 |
CN110078765A (zh) * | 2019-05-17 | 2019-08-02 | 南京望知星医药科技有限公司 | 一种替诺福韦二吡呋酯的制备方法 |
CN114591367B (zh) * | 2022-03-16 | 2023-12-08 | 安徽贝克制药股份有限公司 | 一种富马酸替诺福韦二吡呋酯连续化生产方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103396451A (zh) * | 2013-08-08 | 2013-11-20 | 深圳科兴生物工程有限公司 | 富马酸替诺福韦二吡呋酯中间体的制备方法 |
CN104672281A (zh) * | 2015-02-13 | 2015-06-03 | 安徽安科恒益药业有限公司 | 一种制备高纯富马酸替诺福韦二吡呋酯的方法 |
WO2015161785A1 (zh) * | 2014-04-21 | 2015-10-29 | 四川海思科制药有限公司 | 氨基磷酸酯类衍生物制备方法及其中间体和中间体的制备方法 |
CN105622671A (zh) * | 2016-02-26 | 2016-06-01 | 广东京豪医药科技开发有限公司 | 一种可工业化大生产富马酸替诺福韦二吡呋酯的制备方法 |
-
2018
- 2018-04-03 CN CN201810296698.4A patent/CN108586532B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103396451A (zh) * | 2013-08-08 | 2013-11-20 | 深圳科兴生物工程有限公司 | 富马酸替诺福韦二吡呋酯中间体的制备方法 |
WO2015161785A1 (zh) * | 2014-04-21 | 2015-10-29 | 四川海思科制药有限公司 | 氨基磷酸酯类衍生物制备方法及其中间体和中间体的制备方法 |
CN104672281A (zh) * | 2015-02-13 | 2015-06-03 | 安徽安科恒益药业有限公司 | 一种制备高纯富马酸替诺福韦二吡呋酯的方法 |
CN105622671A (zh) * | 2016-02-26 | 2016-06-01 | 广东京豪医药科技开发有限公司 | 一种可工业化大生产富马酸替诺福韦二吡呋酯的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108586532A (zh) | 2018-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108586532B (zh) | 一种富马酸替诺福韦二吡呋酯的制备方法 | |
EP3436455A1 (en) | Novel salts and crystals | |
KR20210057032A (ko) | 메틸 6-(2,4-디클로로페닐)-5-[4-[(3s)-1-(3-플루오로프로필)피롤리딘-3-일]옥시페닐]-8,9-디히드로-7h-벤조[7]아눌렌-2-카르복실레이트의 염 및 이의 제조 방법 | |
CN103764637A (zh) | 卡巴他赛的固态形式及其制备方法 | |
CN103930423A (zh) | 吡唑并喹啉衍生物 | |
CN107033079B (zh) | 醋酸艾司利卡西平的制备方法 | |
CN105037188B (zh) | 用于制备拉非酰胺甲磺酸盐或其r‑对映异构体的方法 | |
CN114007606B (zh) | 呋喃并咪唑并吡啶类化合物的合成方法、多晶型物、及盐的多晶型物 | |
US20120101273A1 (en) | Novel crystal forms of adefovir dipivoxil and processes for preparing the same | |
CN109400577B (zh) | 利伐沙班有关化合物及其制备方法和用途 | |
CN113004244A (zh) | 一种曲格列汀杂质及其制备方法和用途 | |
WO2022199591A1 (zh) | 一种氟取代的吡啶并吡唑类化合物的晶型及其制备方法 | |
CN116082309A (zh) | 嘧啶衍生物1d228盐酸盐晶型及其制备方法和应用 | |
CN114790210A (zh) | 一种核苷类化合物盐的晶型 | |
CN104379557A (zh) | 阿戈美拉汀晶型i的制备方法 | |
CN117098756A (zh) | 一种环丙基取代的苯并呋喃类化合物的晶型及其制备方法 | |
JP2024504811A (ja) | 三環式化合物及びその使用 | |
CN109293682A (zh) | 一种托法替布杂质及其制备方法 | |
CN108727417B (zh) | 多环化合物钠盐及其多晶型、制备方法及应用 | |
CN114478509B (zh) | 五元杂环取代的苯甲酰胺类化合物及其制备方法与应用 | |
CN115836069B (zh) | 一种二氢吡啶并[2,3-d]嘧啶酮衍生物的盐、其制备方法及用途 | |
CN113861255B (zh) | 一种别孕烷醇酮有关物质的制备方法 | |
US20230203040A1 (en) | Crystalline forms of a sulfonamide compound and processes for preparing the same | |
JP5077232B2 (ja) | ベンゾオキサジアゾール誘導体の結晶 | |
WO2024051771A1 (zh) | 一种五元并六元杂环化合物的晶型及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 2666 Chuangye Road, Mingshui Development Zone, Zhangqiu District, Jinan City, Shandong Province Applicant after: Kexing biopharmaceutical Co., Ltd. Address before: 250200 2666 Chuang Road, Ming Shui development area, Zhangqiu District, Ji'nan, Shandong. Applicant before: Shandong Kexing Biological Product Co., Ltd. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Cui Ning Inventor after: Zhang Yun Inventor before: Zhang Yun Inventor before: Hao Zhihai Inventor before: Chou Duxian Inventor before: Wang Cuicui Inventor before: Cui Ning |
|
GR01 | Patent grant | ||
GR01 | Patent grant |